167 related articles for article (PubMed ID: 18408013)
1. Structure and dynamics of human apolipoprotein CIII.
Gangabadage CS; Zdunek J; Tessari M; Nilsson S; Olivecrona G; Wijmenga SS
J Biol Chem; 2008 Jun; 283(25):17416-27. PubMed ID: 18408013
[TBL] [Abstract][Full Text] [Related]
2. Associations of genotypes at the apolipoprotein AI-CIII-AIV, apolipoprotein B and lipoprotein lipase gene loci with coronary atherosclerosis and high density lipoprotein subclasses.
Peacock RE; Hamsten A; Johansson J; Nilsson-Ehle P; Humphries SE
Clin Genet; 1994 Oct; 46(4):273-82. PubMed ID: 7834891
[TBL] [Abstract][Full Text] [Related]
3. Global structure and dynamics of human apolipoprotein CII in complex with micelles: evidence for increased mobility of the helix involved in the activation of lipoprotein lipase.
Zdunek J; Martinez GV; Schleucher J; Lycksell PO; Yin Y; Nilsson S; Shen Y; Olivecrona G; Wijmenga S
Biochemistry; 2003 Feb; 42(7):1872-89. PubMed ID: 12590574
[TBL] [Abstract][Full Text] [Related]
4. Chylomicronemia due to apolipoprotein CIII overexpression in apolipoprotein E-null mice. Apolipoprotein CIII-induced hypertriglyceridemia is not mediated by effects on apolipoprotein E.
Ebara T; Ramakrishnan R; Steiner G; Shachter NS
J Clin Invest; 1997 Jun; 99(11):2672-81. PubMed ID: 9169497
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein CIII in apolipoprotein B lipoproteins enhances the adhesion of human monocytic cells to endothelial cells.
Kawakami A; Aikawa M; Libby P; Alcaide P; Luscinskas FW; Sacks FM
Circulation; 2006 Feb; 113(5):691-700. PubMed ID: 16461842
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein CIII and diabetes. Is there a link?
Christopoulou E; Tsimihodimos V; Filippatos T; Elisaf M
Diabetes Metab Res Rev; 2019 Mar; 35(3):e3118. PubMed ID: 30557902
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein CIII from guinea pig (Cavia porcellus) is shorter and less homologous than apolipoprotein CIII from other mammals.
Yin Y; Olivecrona G
Comp Biochem Physiol B Biochem Mol Biol; 1999 Oct; 124(2):157-61. PubMed ID: 10584299
[TBL] [Abstract][Full Text] [Related]
8. ABCA1 promotes the de novo biogenesis of apolipoprotein CIII-containing HDL particles in vivo and modulates the severity of apolipoprotein CIII-induced hypertriglyceridemia.
Kypreos KE
Biochemistry; 2008 Sep; 47(39):10491-502. PubMed ID: 18767813
[TBL] [Abstract][Full Text] [Related]
9. Variation at the lipoprotein lipase and apolipoprotein AI-CIII gene loci are associated with fasting lipid and lipoprotein traits in a population sample from Iceland: interaction between genotype, gender, and smoking status.
Peacock RE; Temple A; Gudnason V; Rosseneu M; Humphries SE
Genet Epidemiol; 1997; 14(3):265-82. PubMed ID: 9181356
[TBL] [Abstract][Full Text] [Related]
10. Tryptophan probes reveal residue-specific phospholipid interactions of apolipoprotein C-III.
Pfefferkorn CM; Walker RL; He Y; Gruschus JM; Lee JC
Biochim Biophys Acta; 2015 Nov; 1848(11 Pt A):2821-8. PubMed ID: 26301570
[TBL] [Abstract][Full Text] [Related]
11. Recent Apolipoprotein CIII trials.
Tramontano D; Bini S; D'Erasmo L; Arca M
Curr Opin Lipidol; 2022 Dec; 33(6):309-318. PubMed ID: 36206093
[TBL] [Abstract][Full Text] [Related]
12. DNA polymorphisms at the apolipoprotein A1-CIII loci in Taiwanese: correlation of plasma APOCIII with triglyceride level and body mass index.
Wu JH; Kao JT; Wen MS; Lo SK
J Formos Med Assoc; 2000 May; 99(5):367-74. PubMed ID: 10870325
[TBL] [Abstract][Full Text] [Related]
13. Updates on apolipoprotein CIII: fulfilling promise as a therapeutic target for hypertriglyceridemia and cardiovascular disease.
Zheng C
Curr Opin Lipidol; 2014 Feb; 25(1):35-9. PubMed ID: 24345989
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein CI causes hypertriglyceridemia independent of the very-low-density lipoprotein receptor and apolipoprotein CIII in mice.
van der Hoogt CC; Berbée JF; Espirito Santo SM; Gerritsen G; Krom YD; van der Zee A; Havekes LM; van Dijk KW; Rensen PC
Biochim Biophys Acta; 2006 Feb; 1761(2):213-20. PubMed ID: 16478678
[TBL] [Abstract][Full Text] [Related]
15. The effect of omega-3 carboxylic acids on apolipoprotein CIII-containing lipoproteins in severe hypertriglyceridemia.
Morton AM; Furtado JD; Lee J; Amerine W; Davidson MH; Sacks FM
J Clin Lipidol; 2016; 10(6):1442-1451.e4. PubMed ID: 27919362
[TBL] [Abstract][Full Text] [Related]
16. Role of apolipoprotein CIII in triglyceride-rich lipoprotein metabolism.
Fredenrich A
Diabetes Metab; 1998 Dec; 24(6):490-5. PubMed ID: 9932215
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor 2 mediates apolipoprotein CIII-induced monocyte activation.
Kawakami A; Osaka M; Aikawa M; Uematsu S; Akira S; Libby P; Shimokado K; Sacks FM; Yoshida M
Circ Res; 2008 Dec; 103(12):1402-9. PubMed ID: 18974386
[TBL] [Abstract][Full Text] [Related]
18. HDL-associated apoCIII plays an independent role in predicting postprandial hypertriglyceridemia.
Zhang T; Tang X; Mao L; Chen J; Kuang J; Guo X; Xu D; Peng D; Yu B
Clin Biochem; 2020 May; 79():14-22. PubMed ID: 32045574
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein CIII may mediate the impacts of angiopoietin-like protein 8 on triglyceride metabolism.
Luo M; Su X; Yi Y; Yang Y; Peng D
Lipids Health Dis; 2018 Jul; 17(1):160. PubMed ID: 30021607
[TBL] [Abstract][Full Text] [Related]
20. Lycopene amends LPS induced oxidative stress and hypertriglyceridemia via modulating PCSK-9 expression and Apo-CIII mediated lipoprotein lipase activity.
Alvi SS; Ansari IA; Ahmad MK; Iqbal J; Khan MS
Biomed Pharmacother; 2017 Dec; 96():1082-1093. PubMed ID: 29174038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
